VOYA Investment Management
ANTH

VOYA Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

VOYA Investment Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,456
Closed -$13K – 2529
2016
Q4 		$13K Hold
2,456
– – ﹤0.01% 2524
2016
Q3 		$62 Hold
2,456
– – ﹤0.01% 2522
2016
Q2 		$61K Hold
2,456
– – ﹤0.01% 2536
2016
Q1 		$71K Hold
2,456
– – ﹤0.01% 2456
2015
Q4 		$91K Hold
2,456
– – ﹤0.01% 2494
2015
Q3 		$120K Hold
2,456
– – ﹤0.01% 2448
2015
Q2 		$169K Buy
+2,456
New +$114K ﹤0.01% 2535

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VOYA Investment Management's ANTH Position: Q1 2017 in Review

VOYA Investment Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2017, closing a stake of 2,456 shares — an estimated $13K sold.

VOYA Investment Management first reported a position in ANTH in Q2 2015 and held it in 7 quarters. The position peaked at $169K in Q2 2015. 60 funds tracked by Wall St. Rank hold ANTH as of Q1 2017.

  • VOYA Investment Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • VOYA Investment Management sold 2,456 Anthera Pharmaceuticals, Inc. shares in Q1 2017, an estimated $13K.
  • VOYA Investment Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
  • VOYA Investment Management's Anthera Pharmaceuticals, Inc. position peaked at $169K in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2017.

Based on VOYA Investment Management's 13F filing for Q1 2017, filed 15 May 2017.